KUALA LUMPUR, Oct 6 (Bernama) -- Curia Global Inc (Curia), a global contract, development and manufacturing organisation (CDMO), has announced a strategic investment to expand its sterile active pharmaceutical ingredient (API) manufacturing capabilities for steroid and non-steroid products at its facility in Valladolid, Spain.